3i, LP - 05 Feb 2025 SCHEDULE 13G Report for BriaCell Therapeutics Corp. Common Shares, no par value (BCTX)

Filing Manager
3i, LP
Reporting Manager
3i, LP
Security
BriaCell Therapeutics Corp. Common Shares, no par value
Symbol
BCTX
Shares outstanding
3,727,273 shares
Disclosed Ownership
369,000 shares
Ownership
9.9%
Form type
SCHEDULE 13G
Filing time
10 Feb 2025, 21:02:32 UTC
Date of event
05 Feb 2025
Next filing
13 May 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
3i, LP 9.9% 369,000 0 369,000 /s/ 3i, LP Maier Joshua Tarlow, Manager of 3i Management LLC, General Partner of 3i, LP
3i Management LLC 9.9% 369,000 0 369,000 /s/ 3i Management LLC Maier Joshua Tarlow, Manager
Maier Joshua Tarlow 9.9% 369,000 0 369,000 /s/ Maier Joshua Tarlow Maier Joshua Tarlow